دورية أكاديمية

Comparison between telestroke versus face-to-face thrombolysis models in stroke management in Colombia ; Comparación del modelo de teletrombólisis versus trombólisis presencial en el manejo del ataque cerebrovascular isquémico en Colombia

التفاصيل البيبلوغرافية
العنوان: Comparison between telestroke versus face-to-face thrombolysis models in stroke management in Colombia ; Comparación del modelo de teletrombólisis versus trombólisis presencial en el manejo del ataque cerebrovascular isquémico en Colombia
المؤلفون: Alexandra, A.N.M., B.S.J., Luis, R.C.E., Carlos, J.L.S., Patricia, M.R.B., Alexander, A.P., Alexander, E.M., Álvaro, Alfredo, M.L., Norman, L.V., Loida, C.C.
المصدر: https://www.elsevier.es/en-revista-neurology-perspectives-17-articulo-comparison-between-telestroke-versus-face-to-face-S2667049623000030Test.
بيانات النشر: Ediciones Doyma, S.L.
Spain
سنة النشر: 2023
المجموعة: REDICUC - Repositorio Universidad de La Costa
مصطلحات موضوعية: Modelo de atención, Stroke, Thrombolytic therapy, Telehealth, Healthcare models, Telestroke, Ataque Cerebrovascular Agudo, Terapia Trombolítica, Telemedicina
جغرافية الموضوع: Colombia
الوصف: Introduction: The incidence of stroke continues to rise globally, as it remains an important cause in overall mortality and disability. Given the fact that several patients cannot access thrombolytic therapy due to neurologist unavailability or because of geographic barriers, Teleictus and Telestroke have become reasonable alternatives for providing treatment. Objective: The Teleictus network in Colombia was first implemented in 2018 in Boyacá; Our main goal was to compare the results of two models approaching patient care in stroke: Telestroke versus Face-to-face thrombolysis. Materials and Methods: This was an observational, analytic study using a retrospective cohort. Sociodemographic, clinical, protocol thrombolysis related and clinical evolution variables were considered into the study. Results 65 patients were allocated to the Face-to-face thrombolysis model and 35 were set into the Telestroke model. Median age was 69 and 67 years respectively; both groups had a higher proportion of women than men. Median symptom-onset-to-door time was 136 min in the Face-to-face thrombolysis and 81 min in the Telestroke model p = 0.0083. Median start NIHSS was eleven points for the former and twelve for the latter. At discharge, both groups had a median NIHSS score of 4. Conclusions: Thrombolytic therapy showed safety and efficacy. First and second level institutions are key in the setup of the Telestroke and Teleictus algorithms. More studies are needed to further evaluate this intervention. ; Introducción: el ataque cerebrovascular (ACV) ha aumentado su incidencia global en los últimos años, asociado constituye causa importante de mortalidad y una de las primeras causas de años perdidos por discapacidad. Por ende, es necesario contar con tratamientos que modifiquen el habitual desarrollo natural de la enfermedad. La trombólisis intravenosa con activador tisular del plasminógeno (tPA) es el principal tratamiento de reperfusión sistémica. Los pacientes no pueden acceder a esta terapia por falta de neurólogos y barreras ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: 7 páginas; application/pdf
اللغة: English
تدمد: 2667-0496
العلاقة: Neurology Perspectives; 1. Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–58 1 de mayo de.; 2. Ouriques Martins SC, Sacks C, Hacke W, Brainin M, de Assis Figueiredo F, Marques Pontes-Neto O, et al. Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurol. 2019;18(7):674–83 1 de julio de.; 3. Muñoz NJM, Gómez FR, Martínez MLO, Duran MM, Cardona J. Ministro de Salud y Protección Social; 2022.; 4. Las 10 principales causas de defunción [Internet] [citado 21 de septiembre de 2021]. Disponible en: https://www.who.int/esTest/ news-room/fact-sheets/detail/the-top-10-causes-of-death.; 5. Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):ILXII marzo de.; 6. Mansilla E, Mazzon E, Cárcamo D, Jurado F, Lara L, Arévalo M, et al. Telestroke en Chile: resultados de 1 año de experiencia de la Unidad de TeleACV del Servicio de Salud Metropolitano Sur en 7 hospitales ejecutores. Rev Médica Chile. 2019;147(9):1107–13 septiembre de.; 7. Levine SR, Gorman M. «Telestroke»: the application of telemedicine for stroke. Stroke. 1999;30(2):464–9 febrero de.; 8. Hacke W. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA J Am Med Assoc. 1995;274(13):1017–25 4 de octubre de.; 9. Zarama-Valenzuela Á, Bustos-Sánchez JL, Gordillo-Navas GC, Vargas-Rodríguez LJ, Zarama-Valenzuela Á, Bustos-Sánchez JL, et al. Trombólisis en ataque cerebrovascular isquémico. Experiencia en Boyacá Acta Medica Colomb. 2021;46(1):14–9 marzo de.; 11. Audebert HJ, Kukla C, Clarmann von Claranau S, Kühn J, Vatankhah B, Schenkel J, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the telemedic pilot project for integrative stroke care (TEMPiS) in Bavaria. Stroke. 2005;36(2):287–91 febrero de.; 12. Pinilla-Monsalve GD, Vergara-Aguilar JP, Machado-Noguera B, Gutiérrez-Baquero J, Cabezas-Vargas Z, Bejarano-Hernández J. Estudio de la epidemiología neurológica en Colombia a partir de información administrativa (ESENCIA). Resultados preliminares 2015–2017. Salud UIS [Internet]. 2021:53 20 de septiembre de. [citado 5 de junio de 2022]. Disponible en: https://revistas.uisTest. edu.co/index.php/revistasaluduis/article/view/11958.; 13. Kasab SA, Almallouhi E, Harvey JB, Girotra T, Debenham E, Turner N, et al. Long-term functional outcome for patients treated under drip and stay versus drip and ship paradigm: a single network experience. J Stroke. 2019;21(2):224–7 31 de mayo de.; 14. Moreno E, Rodríguez J, Bayona-Ortiz H. Trombólisis endovenosa como tratamiento del ACV isquémico agudo en Colombia: una revisión sistemática de la literatura. Acta Neurológica Colomb. 2019;35(3):156–66 18 de septiembre de.; 16. Tejada Meza H, Saldaña Inda I, Serrano Ponz M, Ara JR, Marta Moreno J. Impacto en los tiempos puerta-aguja de un conjunto de medidas para optimizar la atención hospitalaria del código ictus. Neurología. 2020 octubre de. S0213485320302735.; 17. López-Cancio E, Ribó M, Cardona P, Serena J, Purroy F, Palomeras E, et al. Telestroke in Catalonia: Increasing Thrombolysis Rate and Avoiding Interhospital Transfers. Cerebrovasc Dis. 2018;46(1–2):66–71.; 18. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. Improving Door-to-Needle Times in Acute Ischemic Stroke. Stroke. 2011;42(10):2983–9 octubre de.; 19. Brunser AM, Hoppe A, Muñoz P, Lavados PM, Illanes S, Díaz V, et al. Thrombolysis in stroke mimics: experience in 10 cases. Rev Médica Chile. 2016;144(10):1266–9 octubre de.; 20. Moulin S, Leys D. Stroke mimics and chameleons. Curr Opin Neurol. 2019;32(1):54–9 febrero de.; 21. Mohamed A, Fatima N, Shuaib A, Saqqur M. Comparison of faceto-face thrombolysis versus drip-and-ship models in treating patients with acute ischemic stroke: A systematic review and meta-analysis. Int J Stroke. 13 de mayo de 2021.; 22. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999;30(11):2280–4 noviembre de.; 23. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245–51 octubre de.; 24. Waseem H, Salih YA, Burney CP, Abel MA, Riblet N, Kim A, et al. Efficacy and safety of the telestroke drip-and-stay model: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2021;30(4):105638 1 de abril de.; 25. Sairanen T, Soinila S, Nikkanen M, Rantanen K, Mustanoja S, Farkkila M, et al. Two years of Finnish telestroke: thrombolysis at spokes equal to that at the hub. Neurology. 2011;76(13): 1145–52 29 de marzo de.; A. N. M. Alexandra et al., “COMPARISON BETWEEN TELESTROKE VERSUS FACE-TO-FACE THROMBOLYSIS MODELS IN STROKE MANAGEMENT IN COLOMBIA.”, Neurol. Perspectives, p. 100111, enero de 2023. doi:10.1016/j.neurop.2023.100111; https://hdl.handle.net/11323/10449Test; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.coTest/
DOI: 10.1016/j.neurop.2023.100111
الإتاحة: https://doi.org/10.1016/j.neurop.2023.100111Test
https://hdl.handle.net/11323/10449Test
https://repositorio.cuc.edu.coTest/
حقوق: © 2023 Sociedad Española de Neurología. ; Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) ; https://creativecommons.org/licenses/by-nc-nd/4.0Test/ ; info:eu-repo/semantics/openAccess ; http://purl.org/coar/access_right/c_abf2Test
رقم الانضمام: edsbas.BECCC0F4
قاعدة البيانات: BASE
الوصف
تدمد:26670496
DOI:10.1016/j.neurop.2023.100111